Cyclodextrin modified green synthesized graphene oxide@iron nanoparticle composites for enhanced removal of oxytetracycline

The presence of residual antibiotics will lead to potential environmental risks. Here cyclodextrins (CDs) were successfully used to modify graphene-based iron nanoparticles (GO@Fe NPs) to enhance the absorption of oxytetracycline hydrochloride (OTC). The removal of OTC decreased in the order: γCD-GO@Fe NPs > βCD-GO@Fe NPs > αCD-GO@Fe NPs > GO@Fe NPs, with better performance than that of bare GO and Fe NPs. Characterization techniques were applied to better understand how CDs impact the structure of GO@Fe NPs and improve removal performance. Raman and X-ray diffraction analysis showed that GO acted as a carrier to support Fe NPs within the grafted cyclodextrin, where GO also participated in the removal process. Cyclodextrin modified GO@Fe NPs had relatively small particle sizes (15 nm), with a high surface area (61.7 m2 · g-1). X-ray photoelectron spectroscopy and Fourier transform infrared spectroscopy suggested that cyclodextrin acted as both a stabilizing and capping agent during green synthesis, which could protect the reactivity of Fe NPs and simultaneously reduce aggregation. A potential synthesis mechanism of cyclodextrins modified composites was also proposed, and subsequent wastewater testing indicated that γCD-GO@Fe NPs had high potential for practical applications.